Biotechnology Operations Venture Capitalist 
Harvard Business Review
MAY 2, 2011
Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies. Last year, at the World Economic Forum's annual meeting in China, we spoke with one of the country's most celebrated scientists, entrepreneurs, and venture capitalists.
Harvard Business Review
FEBRUARY 17, 2011
Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). Editor's Note: This post was written with Justin Chakma, an undergraduate student at the University of Toronto (Canada).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
FEBRUARY 3, 2015
Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway musical industry and biotechnology. Get in touch with a venture capitalist. He then mapped out the network of who consulted with whom. Start a LinkedIn or Facebook group. Learn from your students.
Harvard Business Review
OCTOBER 26, 2011
Many venture capitalists are limiting their investments to the "demand-side" — aimed at reducing energy use — rather than investing in startups trying to change the way we produce energy. Their behavior displays promising parallels to the early days of the biotechnology industry.
Harvard Business Review
JUNE 16, 2016
“But here, we can operate within the time frame of the next coffee break.” “Venture capitalists are looking for rapid exits and researchers are pretty much stuck with the idea that they came to the party with. Congress has recently passed legislation to expand the program and ensure its continuity.
Expert insights. Personalized for you.
15 
Let's personalize your content